Product Information

PIOGLITAZONE HCL 15 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0647 per EA under NDC 00093727105. Its NADAC has been published 597 times since Mar 18, 2015.

FDA first approved this application on Jan 10, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PIOGLITAZONE HCL 15 MG TABLET

Pioglitazone
$0.0647per EA

Strength

15 mg/1

NDC

00093727105

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PIOGLITAZONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA077210

FDA Approved

1/10/2014

TE Code

AB

On Market Since

2/4/2015

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE HCL 15 MG TABLET has been published 597 times since Mar 18, 2015, and over the history we have for it it has declined 60.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0647 per EA
All-time high$0.1680 (May 13, 2015)
All-time low$0.0587 (Nov 20, 2024)
52-week high$0.0727
52-week low$0.0647
Median price$0.0923
Average price$0.0998
Largest weekly change-25.8% (Nov 20, 2024)
Weeks tracked597
Tracking sinceMar 18, 2015

Price History

1W

-2.2%

1M

-2.2%

3M

-7.7%

6M

-5.6%

1Y

-11.0%

3Y

-23.4%

5Y

-42.1%

All

-60.9%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE HCL 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 15 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0647 per EA (NDC 00093727105), effective Aug 19, 2026.

How has the price of PIOGLITAZONE HCL 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE HCL 15 MG TABLET has declined 60.9%. It has been tracked across 597 weekly CMS publications since Mar 18, 2015.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 15 MG TABLET?

Since Mar 18, 2015, the NADAC for PIOGLITAZONE HCL 15 MG TABLET has ranged from a low of $0.0587 (Nov 20, 2024) to a high of $0.1680 (May 13, 2015), with a median of $0.0923 per EA.

Are there cheaper alternatives to PIOGLITAZONE HCL 15 MG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PIOGLITAZONE HCL 15 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PIOGLITAZONE HCL 15 MG TABLET?

PIOGLITAZONE HCL 15 MG TABLET (NDC 00093727105) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.